A day after Madrigal Pharmaceuticals impressed investors, Novo Nordisk is looking to steal the spotlight.
The Danish drugmaker reported Friday that …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.